Ticker
JNJ

Price
145.45
Stock movement up
+0.04 (0.03%)
Company name
Johnson & Johnson
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers-General
Market cap
453.78B
Ent value
550.23B
Price/Sales
4.78
Price/Book
5.91
Div yield
3.41%
Div growth
5.83%
Growth years
58
FCF payout
128.44%
Trailing P/E
25.29
Forward P/E
13.36
PEG
3.95
EPS growth
68.98%
1 year return
-9.51%
3 year return
-4.11%
5 year return
0.53%
10 year return
3.40%
Last updated: 2024-06-13

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

BUSINESS INSIGHT

Segment Revenues ($M)

Loading...
Operations comments

In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization

In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission

The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021

Geographic Revenues ($M)

Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share4.96
Dividend yield3.41%
Payout frequencyQuarterly
Maximum yield3.64%
Average yield2.76%
Minimum yield2.36%
Discount to avg yield19.01%
Upside potential23.47%
Yield as % of max yield93.81%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield3.41%
Current yield distribution0.63%
Yield at 100% (Min)2.36%
Yield at 90%2.51%
Yield at 80%2.56%
Yield at 50% (Median)2.72%
Yield at 20%2.95%
Yield at 10%3.04%
Yield at 0% (Max)3.64%

Dividend per share

Loading...
Dividend per share data
Years of growth58 years
CCC statusDividend Champion
Dividend per share4.96
Payout frequencyQuarterly
Ex-div date20 May 2024
EPS (TTM)6.73
EPS (1y forward)10.89
EPS growth (5y)68.98%
EPS growth (5y forward)6.40%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
JNJS&P500
DGR MR4.20%-16.32%
DGR TTM5.02%4.05%
DGR 3 years5.70%5.24%
DGR 5 years5.83%5.40%
DGR 10 years6.14%7.07%
DGR 15 years6.63%6.12%
Time since last change announced67 days
EPS growth (5y)68.98%
EPS growth (5y forward)6.40%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM65.11%128.44%
Average--
Forward45.55%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E25.29
Price to OCF21.41
Price to FCF49.89
Price to EBITDA14.29
EV to EBITDA17.33

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.78
Price to Book5.91
EV to Sales5.80

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count3.12B
EPS (TTM)6.73
FCF per share (TTM)3.41

Income statement

Loading...
Income statement data
Revenue (TTM)94.94B
Gross profit (TTM)63.85B
Operating income (TTM)23.84B
Net income (TTM)17.94B
EPS (TTM)6.73
EPS (1y forward)10.89

Margins

Loading...
Margins data
Gross margin (TTM)67.26%
Operating margin (TTM)25.11%
Profit margin (TTM)18.90%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash14.13B
Net receivables19.29B
Total current assets55.29B
Goodwill45.23B
Intangible assets48.33B
Property, plant and equipment0.00
Total assets187.38B
Accounts payable11.70B
Short/Current long term debt39.66B
Total current liabilities55.80B
Total liabilities110.57B
Shareholder's equity76.80B
Net tangible assets-16.75B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)21.19B
Capital expenditures (TTM)4.01B
Free cash flow (TTM)9.10B
Dividends paid (TTM)11.68B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity23.36%
Return on Assets9.57%
Return on Invested Capital15.40%
Cash Return on Invested Capital7.81%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open145.07
Daily high146.00
Daily low143.88
Daily Volume6.74M
All-time high186.01
1y analyst estimate180.90
Beta0.53
EPS (TTM)6.73
Dividend per share4.96
Ex-div date20 May 2024
Next earnings date17 Jul 2024

Downside potential

Loading...
Downside potential data
JNJS&P500
Current price drop from All-time high-21.81%-
Highest price drop-38.78%-56.47%
Date of highest drop11 Aug 19939 Mar 2009
Avg drop from high-9.61%-11.29%
Avg time to new high20 days13 days
Max time to new high1038 days1805 days
COMPANY DETAILS
JNJ (Johnson & Johnson) company logo
Marketcap
453.78B
Marketcap category
Large-cap
Description
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment provides skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. This segment also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment provides products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes, and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment offers electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and contact lenses and ophthalmic technologies related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Employees
152700
SEC filings
CEO
Alex Gorsky
Country
USA
City
New Brunswick
Stock type
Common stock
CCC status
Dividend Champion
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...